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Abstract
Background: The small GTPase rab1a and its isoform rab1b are essential regulating components
in the vesicle transport between the ER and the Golgi apparatus. Rab1 is thought to act as a
molecular switch and can change between an active GTP-bound and an inactive GDP-bound
conformation. To elucidate the function of rab1, several approaches have been established to
isolate effector proteins, which interact with the activated conformation of rab1. To date p115,
GM130, golgin-84 and MICAL have been identified as direct interacting partners. Together with
rab1, these molecules are components of a protein complex, which mediates and regulates
intracellular vesicle transport.
Results: Here, we report the characterization of Iporin, which is similar to KIAA0375 as a novel
rab1-interacting protein. It was initially identified by yeast two-hybrid screening experiments with
the active mutant of rab1b (rab1b Q67R) as bait. Iporin contains a SH3 domain and two polyproline
stretches, which are known to play a role in protein/protein interactions. In addition, Iporin
encloses a RUN domain, which seems to be a major part of the rab1binding domain (R1BD). Iporin
is ubiquitously expressed and immunofluorescence staining displays a cytosolic punctual
distribution. Interestingly, we also show that Iporin interacts with another rab1 interacting partner,
the GM130 protein.
Conclusion: Our results demonstrate that Iporin is a potential new interacting partner of rab1.
Iporin is different from already identified rab1 interacting proteins concerning protein structure
and cellular localization. We conclude that Iporin might function as a link between the targeting of
ER derived vesicles, triggered by the rab1 GTPase and a signaling pathway regulated by molecules
containing SH3 and/or poly-proline regions. The characterization of this novel intermolecular
relation could help to elucidate how vesicles find their way from ER to the Golgi apparatus.
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Background
The rab/Ypt proteins represent a large family of small
GTPases involved in several transport steps of the cellular
trafficking pathway. At present 11 members have been
identified in yeast and more than 60 human rab proteins
are supposed [1,2]. Small GTPases are known to function
as molecular switches and can cycle between an active
GTP-bound and an inactive GDP-bound conformation
[3,4]. In the active conformation, the rab GTPases are
localized on membranes, where they recruit specific effec-
tor molecules to mediate vesicle attachment [5]. The sub-
sequent fusion step is initiated, when the membranes are
forced into close proximity by the interaction of SNARES
(soluble N-ethylmaleimide-sensitive factor attachment
protein receptor) presented on both membranes in con-
cert with SM proteins (Sec1/Munc18-like proteins),
thought to act as controlling elements in SNARE interac-
tion [6].
The two isoforms of the small GTPase rab1 (rab1a/b) are
localized on ER-Golgi membranes and regulate the exocy-
totic transport from the ER to the Golgi apparatus [7-9].
Although the function of rab1 is still not fully understood,
several lines of evidence describe rab1 and its yeast
homolog Ypt1p GTPase as a major component in a pro-
tein complex responsible for directing vesicular traffic
between the ER and the Golgi apparatus [7-13]. In the
past, several approaches have been established to identify
effector molecules that bind specifically to the active GTP-
bound form of rab1 [14-17]. At present, four specific
effector proteins and several additional putative effector
molecules are known [14]. The first characterized rab1
interacting protein was p115, which also binds to the
Golgi-associated proteins GM130 and Giantin [14,18,19].
p115 is the mammalian homologue of the yeast protein
Uso1p, which was found to be an essential component
necessary for the tethering of ER-derived COP II vesicles to
the Golgi compartment, a process that depends on Ypt1p,
but is independent of SNARE proteins [20]. In addition,
p115 plays a key role in coordinating sequential tethering
and docking of COPI vesicles to Golgi membranes. Thus,
it is thought to function as a linker protein between Gian-
tin and GM130 [19,21,22]. Second, the cis-Golgi matrix
protein GM130 was identified as a direct rab1 effector,
which also binds to a complex containing GRASP65, a
lipid-anchored GM130-binding protein, that regulates
Golgi stack reformation following mitosis, as well as so far
uncharacterized proteins [15,17,23,24]. A third interact-
ing molecule of activated rab1, golgin-84, is supposed to
act as a novel mitotic target [16]. Overexpression or deple-
tion of golgin-84 results in fragmentation of the Golgi rib-
bon and the protein is thought to be required for the
incorporation of membranes into the Golgi apparatus
[16,25]. Golgin-84 is a type II C-terminally anchored cis-
Golgi protein with an extensive cytoplasmic coiled-coil
domain, which shows structural and sequence similarity
to Giantin [26]. However, golgin-84 does not appear to
physically interact with other cis-Golgi matrix proteins
such as GM130, p115 or GRASP65 and therefore it is
likely, that additional potential golgin84-binding mole-
cules exist [16]. Recently, we identified MICAL as a fourth
rab1 interacting partner and suggested a link between the
Golgi apparatus associated rab1 and the intermediate fil-
ament cytoskeleton [27].
Here, we describe Iporin as a novel interacting molecule
for the active GTP-bound conformation of rab1. Iporin
(Interacting protein of rab1) was identified in a yeast two-
hybrid screen with rab1b Q67R as bait and sequence anal-
yses revealed, that the encoded protein is similar to the C-
terminal half of the KIAA0375 polypeptide. The rab1b-
Iporin interaction is nucleotide-dependent and rab1-spe-
cific. Interestingly, the rab1 binding motif of Iporin was
mapped to a region containing a RUN domain, a protein
motif, which is known to be involved in the function of
small GTPases. Furthermore we examined the intracellu-
lar localization and tissue-specific expression of Iporin
and give insight into its domain structure. Interestingly
our results also showed an interaction with the rab1 effec-
tor GM130 via its coiled-coil region 6 [15].
Results
Identification of a novel rab1 interacting protein
With the rab1b Q67R mutant as bait and a human pla-
centa cDNA library as prey we performed yeast two-hybrid
screening assays to identify novel interacting partners for
the active GTP-bound conformation of the small GTPase
rab1b. One of the isolated clones could be identified as
the human Golgi matrix protein GM130 and a second
clone encoded for a fragment of MICAL1b [15,27].
Another interesting clone was K17, which displayed a
strong and specific interaction with rab1b Q67R in the
yeast two-hybrid system (Table 1). Nucleotide sequence
analysis revealed that K17 represents the cDNA sequence
encoding the C-terminus of KIAA0375 (GenBank Acces-
sion number: AB002373.2). We named the identified pro-
tein Iporin (for Interacting protein of rab1) and the
deleted K17 clone Iporin ∆ N847. Since the rab1 effector
GM130 has been shown to interact with various rab pro-
teins (rab1, rab2, rab33b), we wanted to investigate the
rab1 specificity of the Iporin interaction [16,23,28]. Thus,
we used an assortment of rab cDNA molecules as bait con-
structs in yeast co-transformation assays (Table 1). Iporin
∆ N847 (K17) induced strong growth and β -galactosidase
activity only, when co-transformed with the permanent
active mutants of rab1b (rab1bQ67R/L) and rab1a (rab1a
Q70L).
Interestingly, an interaction between Iporin ∆ N847 and
the wild type as well as the permanently active mutant ofBMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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the yeast counterpart of mammalian rab1, Ypt1p, was
observed pointing to a conserved interaction of these two
molecules [5]. The empty pAS2-1 vector, the wildtypes of
the rab1 isoforms (rab1a/b), permanently inactive
mutants of the rab1a/b (rab1a S25N, rab1b S22N) and
Ypt1p (Ypt1 S22N) proteins were not able to significantly
activate reporter gene expression (Table 1). There were
also no interactions of Iporin∆ N847 with the small
GTPases rab6 and rab2 (Table 1). These results indicate,
that the interaction with Iporin ∆ N847 is rab1-specific
and requires the GTP-bound, active conformation of rab1.
Mapping the Iporin binding site of rab1b
Next, we wanted to analyze, which structural elements of
rab1b are necessary or sufficient for the interaction with
Iporin. Since we already demonstrated that the hypervari-
able regions of rab1 are necessary for an interaction with
GM130, we created rab1b mutants as well as rab1/rab6
chimeras (Figure 1A) [15,29]. The mutants and the chime-
ras enabled us to restrict specific regions for the interac-
tion to the C- or N-terminal half of rab1. Co-
transformation experiments in yeast revealed that only the
rab1b deletion mutant rab1b Q67R ∆ C197 lacking the
prenylation site of rab1b showed a strong interaction with
Iporin ∆ N847, suggesting that the prenylation site is not
necessary for the interaction with Iporin ∆ N847 (Figure
1B). The deletion mutants rab1b Q67R ∆ N9, rab1b Q67R
∆ C163 and rab1b Q67R ∆ C163-196 failed to interact with
Iporin  ∆ N847 (Figure 1B). These mutants were con-
structed based on the model previously proposed by
Bourne et al. and Valencia et al.. G1-G3 and PM1-PM3 are
conserved regions in all members of the ras superfamily of
GTPases, that are involved in guanine (G) and phosphate/
Mg2+ (PM) binding, respectively [3,4,30]. According to the
proposed model suggested by Seabra and coworkers,
which defined rab conserved sequences as rab family
motifs (RabF1-5) and other regions as subfamily motifs
(RabSF1-4), the generated mutants lack the RabSF1 or
RabSF4 region (Figure 1A) [31]. Co-transformation with
the two rab1/rab6 chimeras displayed an interaction
between the C1- and C2-rab1b Q67R-rab6a chimera and
Iporin/Iporin ∆ N847, but not between the rab6a Q72L-
rab1b chimera and Iporin ∆ N847 (Figure 1B).
Full-length cloning and characterization of Iporin
Sequence analysis of the clone K17 cDNA revealed an
open reading frame of 669 amino acids, which was iden-
tical to the C-terminal half of the protein encoded by the
KIAA0375 cDNA (aa 848–1516). To obtain the full-
length Iporin sequence, we used the KIAA0375 cDNA for
the amplification of the sequence encoding the missing
N-terminal fragment by PCR.
Information about the genomic structure of Iporin pro-
tein was obtained from the human genome database. The
Iporin gene consists of ~14 kb of genomic sequence and
contains eleven exons (Figure 2A). The gene is located on
the short arm of chromosome 9 (9p13.1) and comprises
4548 bp of coding DNA. Deduced from the cDNA
sequence, Iporin comprises 1516 amino acids with a cal-
culated molecular mass of 161.195 kDa and an acidic pI
of 6.17. Further structure analysis revealed functional
domains and motifs in the Iporin sequence (Figure 2B).
Iporin contains some low complexity regions, which
include polyproline (pP) and polyglutamic acid (pE)
stretches. The first polyproline stretch is localized between
aa 429 and aa 442 with the sequence PPPGPGPDPGPSQP
and a second region between aa 1311 and aa 1319 with
the sequence PPQAPPP. Proline-rich stretches are known
to interact with SH3 or WW domains and could mediate
further protein/protein interactions [32]. The poly-
glutamic acid stretch, spanning aa 1236 – 1252 with the
sequence EGGEEEEEEEETEEVAE is flanked by the two
proline-rich regions. This motif is highly negatively
Table 1: Interaction of Iporin ∆ N847 with different rab proteins/
isoforms
prey Iporin ∆ N847
bait control his3 lacZ
pAS2-1 +++ - -
rab1a wt +++ + +/-
rab1a S25N +++ - -
rab1a Q70L +++ +++ +++
rab1b wt +++ +/- -
rab1b S22N +++ - -
rab1b Q67R +++ ++ +++
rab1b Q67L +++ ++ +++
rab2 wt +++ - -
rab2 S20N +++ - -
rab2 Q65L +++ - -
rab6 wt +++ - -
rab6 T27N +++ - -
rab6 Q72R +++ - -
Ypt1 wt +++ ++ ++
Ypt1 S22N +++ - -
Ypt1 Q67L +++ +++ +++
Results obtained from co-transformation assays in yeast. Clones were 
cultivated on selection plates lacking tryptophan and leucine (control) 
or lacking additionally histidine and were supplemented with 50 mM 
3-aminotriazol (his3). The β -galactosidase activity was determined 
using X-gal as substrate on filter lift assays (lacZ). - = no growth on 
selection plates or no β -galactosidase activity; +/- = background 
growth or β -galactosidase activity appears overnight; + = slow 
growth; ++ = strong growth or β -galactosidase activity appears after a 
few hours; +++ = very fast growth or high β -galactosidase activity.BMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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Determination of the Iporin interacting domain Figure 1
Determination of the Iporin interacting domain. (A) Schematic overview of the domain structure of rab1b with the 
conserved G1-G3 boxes, PM1-3 motifs, N-terminal and C-terminal hypervariable regions (hpr) and the C-terminal prenylation 
site (ps). SF1-4 indicate the rab subfamily regions. The rab1b regions of the chimeras are shaded dark and the rab6 regions are 
light-shaded. (B) All constructs were co-transformed in yeast and cells were cultivated on selection plates as described above 
(Table 1). Rab1b deletion mutants were co-transformed with Iporin ∆ N847, whereas chimeras were co-transformed with full-
length Iporin. - = no growth on selection plates or no β -galactosidase activity; +/- = background growth or β -galactosidase 
activity appears overnight; ++ = strong growth; +++ = very fast growth or high β -galactosidase activityBMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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charged and may play a role in stabilizing the protein or
function as further interaction domain.
Using the Motif Scan Software http://www.expasy.org we
also detected a RUN (RPIP8, UNC-14 and NESCA)
domain in the Iporin sequence (aa 1031–1175; Figure
2B). This domain was shown to be involved in the func-
tion of small GTPases and can also be found in proteins
which play a role in proliferation, differentiation and
motility [33,34]. The RUN domain is organized in six con-
served blocks (Figure 2C; A-F), which are predicted to con-
stitute the "core" of a globular structure. Figure 2C shows
an alignment of different RUN domains containing pro-
teins related to small GTPases like RPIP8, Rabip4, Rufy1,
NESCA or Iporin [34-36]. RUN domain containing pro-
teins enclose hydrophobic amino acids in conserved posi-
tions as shown by shaded or boxed regions (Figure 2C).
The secondary structure of the RUN domain core was pre-
dicted to consist of predominantly α -helices and the con-
served three dimensional structure is probably of
importance. However, the exact function of this motif is
still unclear [33].
Interestingly, NESCA (new molecule containing SH3 at
the carboxy-terminus) and Iporin share 42% of sequence
homology and contain both a SH3 domain at the C-termi-
nus. The function of NESCA is not known, but it is
thought to be involved in signal transduction pathways
and was recently described as a signaling adaptor which
shuttles from the cytosol to the nuclear envelope [37,38].
We used NESCA as a prey for yeast two-hybrid assays to
investigate, whether NESCA might be a further interacting
partner of the small GTPase rab1. However, we were not
able to show an interaction between NESCA and rab1
(data not shown).
BLAST searches revealed a mouse homolog of Iporin, EST
clone AI840675, which shows 84% similarity to the
human protein. This clone encodes 736 amino acids,
which are homologous to Iporin aa 723 to 1455. The
truncated mouse Iporin protein contains only a RUN
domain and we suppose that it might function in a differ-
ent, but related manner, to human Iporin. The C-terminus
of Iporin contains a SH3 domain (aa 1447–1500), which
is found in a variety of proteins (Figure 2B) [39]. This
domain is known to interact with polyproline domains in
target molecules and is involved in transmembrane sign-
aling and cytoskeletal rearrangements [40]. To identify the
interacting motif of the SH3 domain of Iporin we per-
formed a phage displayed analysis. For this purpose we
screened a fUSE5/15-mer M13 phage displayed random
peptide library using purified GST-Iporin SH3 (Iporin
∆ N1430) as a target. Sequencing of the cDNA from phages
with a high and specific affinity towards GST-Iporin SH3
identified a new consensus motif (Figure 2D). This motif
contains two prolines followed by an aliphatic amino acid
(A, I, L, V), two further amino acids and a conserved
methionine (PPΨ X2M).
Mapping the rab1 binding domain of Iporin
To investigate, which part of the Iporin sequence acts as a
rab1 binding domain (R1BD), we generated several dele-
tion mutants of Iporin (Figure 3A) and tested them in
yeast two-hybrid assays (Figure 3B). As expected, the N-
terminus of the protein (Iporin ∆ C853), which is not
present in the original prey clone as well as the SH3
domain (Iporin ∆ N1430) are not necessary for the inter-
action with rab1b and failed to activate the reporter genes
(Figure 3B). Only the RUN domain-containing mutants
(Iporin  ∆ N847,  ∆ N847∆ C1450,  ∆ N847∆ C1239,
∆ N991∆ C1177,  ∆ N991∆ C1239 and ∆ N991∆ C1450)
showed growth and β -galactosidase activity on selection
plates (Figure 3B). Interestingly, the interaction of rab1b
with the shortest RUN domain containing mutants
(∆ N991∆ C1177,  ∆ N991∆ C1239, respectively) was
weaker compared to fragments containing longer flanking
sequences, which could result from protein misfolding.
To confirm the yeast two-hybrid mapping results, we per-
formed GST-pulldown assays. Bacterially expressed GST-
Iporin  ∆ N847∆ C1239, GST-Iporin ∆ N847∆ C992 and
GST were coupled to glutathione-Sepharose and incu-
bated with extract from BHK cells overexpressing HA-
tagged rab1b Q67R (Figure 3C). In this assay, the GST-
Iporin ∆ N847∆ C1239 was able to bind to the active form
of rab1b, whereas GST and GST-Iporin ∆ N847∆ C992
failed to interact (Figure 3C). These findings confirmed
the yeast data (Figure 3B) and indicate that the rab1 bind-
ing domain of Iporin needs the whole RUN motif.
Tissue-specific expression and cellular localization of 
Iporin
Northern blot analysis of various human tissues indi-
cated, that Iporin is ubiquitously expressed. The Iporin
mRNA was identified as a prominent band of approxi-
mately 5.5 kb. Highest amounts of Iporin transcripts were
observed in brain and testis (Figure 4). These findings are
consistent with the RT-PCR results, published by the
Kazusa institute, Japan.
The cellular distribution of Iporin was examined by
cytosol/membrane fractionation and
immunofluorescence.
Although the calculated mass of Iporin (deduced from the
cDNA sequence) is 161,195 kDa, the endogenous protein
is detected at about 220 kDa in Western blot analyses (Fig.
5Ac first row). We assume that the molecular weight shift
observed in the Western blot analyses could result from
posttranslational modifications within theBMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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2 Genomic structure and functional elements of Iporin Figure 2
2 Genomic structure and functional elements of Iporin. (A) Schematic representation of the human Iporin gene 
located on chromosome 9. The protein coding exons of Iporin are shown as shaded boxes numbered one to eleven, non-cod-
ing sequences are white. The gene (~14 kb) encodes a protein of 1516 amino acids. (B) Domains and structural motifs of 
Iporin. The most interesting domains within Iporin are the SH3 (aa 1447–1500) and the RUN domain (aa 1031–1175). The 
proline-rich motifs (pP, aa 429–442; aa 1311–1319) are possible interaction motifs for SH3 or WW domain containing pro-
teins. The glutamic acid-rich region (pE, aa 1236–1252) is negatively charged with possibly stabilizing function. (C) Alignment of 
RUN domains from related proteins. The sequence corresponding to the RUN domain of Iporin (aa 1031–1175, human) was 
aligned to the RUN domains present in AI840675 (aa 309–453, mouse), NESCA (aa 53–197, human), RPIP8 (aa 52–189, 
human), Rabip4 (aa 31–163, mouse) and Rufy1 (aa 31–163, human) (GenBank accession numbers, XP_131380.2, BAA77507.2, 
NP_006686.1, CAC17732.1 and AAK50771.1, respectively). RUN domains were detected using the Motif Scan software http:/
/www.expasy.org. Hydrophobic residues (V, L, I, F, Y, W, M, C) are show as boxes, conserved positions are shaded. A-F are 
the six conserved blocks, and distances between these blocks are indicated by the numbers of residues in parentheses. (D) 
Alignment of sequenced clones identified by phage display using the Iporin SH3 domain. Four different clones were isolated, 
whereby the number of independent clones, which contained the same sequence, are in brackets. The conserved consensus 
motif is shaded. Ψ  = aliphatic amino acid; X2 = two individual amino acids.BMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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Mapping the rab1 binding domain (R1BD) of Iporin Figure 3
Mapping the rab1 binding domain (R1BD) of Iporin. (A) Overview of deletion mutants used for yeast co-transforma-
tion assays. The deletion mutants ∆ Nx or ∆ Cx do not contain the N-terminus or the C-terminus, respectively. We were able 
to map the rab1 binding domain (R1BD) to a RUN domain containing region. (B) Results obtained from yeast co-transforma-
tions. The bait construct rab1b Q67R was cloned into the pAS2-1 vector and the prey constructs into pGADT7. Clones were 
cultivated on selection plates as described previously (see Table 1). (C) GST-pulldown with coupled GST-Iporin 
∆ N847∆ C1239 indicated an interaction with Iporin, whereas GST-Iporin ∆ N847∆ C992 and GST were negative. The lower 
panel shows the Coomassie blue stained blot membrane with equal amounts of GST fusion protein. - = no growth on selection 
plates or no β -galactosidase activity; +/- = β -galactosidase activity appears overnight; + = slow growth or β -galactosidase activ-
ity appears after several hours; ++ = strong growth; +++ = very fast growth or high β -galactosidase activity; pP = polyproline; 
pE = polyglutamic acid.BMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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aminoterminal part of the Iporin molecule, because tran-
sient transfections in HeLa cells with aminoterminal con-
structs showed the highest difference between measured
and calculated weight (data not shown). However, in
lysates from transfected HeLa cells expressing HA-tagged
full length Iporin, the affinity-purified antibody Aip519
detected a 220 kDa protein as did the 16B12 antibody,
which is directed against the HA epitop (Figure 5Aa).
To obtain information about the membrane association
of Iporin, we performed cytosol/membrane fractionation
and therefore we transiently transfected HeLa cells with
vectors encoding full-length Iporin, an aminoterminal
fragment (Iporin ∆ C853) or the C-terminal fragment
(Iporin  ∆ N847), respectively (Figure 5Ab). Transfected
cells were lysed and extracts were separated by differential
centrifugation steps into cytosol (S100) and membrane
(P100) fractions. Equal amounts of protein were analyzed
by Western blotting. Calnexin distribution was used as a
marker for integral membrane proteins to verify the purity
of the fractions (not shown). Our data demonstrate that
full-length HA-Iporin and HA-Iporin ∆ N847 seem to
associate with cellular membranes or insoluble parts of
cells, because major part of the proteins was detected in
the P100 fractions (Figure 5Ab). Interestingly, the HA-
Iporin ∆ C853 mutant, which lacks the C-terminus was
highly enriched in the cytosolic fraction, indicating that
parts of the C-terminus play an important role in the cel-
lular localization of Iporin (Figure 5Ab). To address the
question, whether the overexpression of permanently
active rab1b influences the cellular distribution of Iporin,
we transiently transfected HeLa cells with vectors encod-
ing for HA-tagged rab1b Q67L and performed further frac-
tionations (Figure 5Ac). The comparison between non-
transfected and transfected HeLa cells showed, that the
overexpression of HA-rab1b Q67L had no remarkable
effect on the distribution of Iporin. GM130, p115 and
Calnexin were used as control proteins and showed as
well no significant changes.
Hence our Aip519 polyclonal antibody was inapplicable
for immunohistochemistry we transiently transfected
HeLa cells with HA tagged Iporin and used the anti HA-
antibody 16b12 for staining. The immunofluorescence
shows a cytosolic pattern of HA-Iporin, enriched in small,
brighter spots. However, most of the cells showed a faint
perinuclear enriched fluorescence where usually the
Golgi/ER structures are localized (Figure 5B).
Iporin interacts with the Golgi matrix protein GM130
Surprisingly, yeast two hybrid co-transformation experi-
ments showed an additional interaction between the two
rab1 binding proteins Iporin and GM130. Mapping of the
binding site of GM130 revealed, that the coiled-coil
domain 6 is responsible for the interaction with Iporin,
whereas GM130 coiled-coil domain 3 mediates the
interaction with rab1b (Figure 6A) [15]. To confirm the
yeast data, we performed in vitro binding assays. Recom-
binant GST-Iporin ∆ N847∆ C1239 as well as GST-Iporin
∆ N1430 proteins were coupled to glutathione Sepharose
beads and then incubated with HeLa SS6 cell extracts,
which expressed the GM130 protein in considerable
amounts. After washing steps, the bound proteins were
separated by SDS-page and analyzed by Western blotting
analysis using GM130 antibodies. As shown in figure 6B,
only GST-Iporin ∆ N847∆ C1239 is able to bind to endog-
enous GM130, whereas the GST-Iporin∆ N1430 was una-
ble to interact (Figure 6B).
Discussion and conclusions
The cellular function of the small GTPase rab1 is not fully
understood, thus the identification of novel rab1 interact-
ing molecules may help to elucidate its role in vesicular
transport. Using the yeast two-hybrid system, we were
able to isolate Iporin as a new protein, which specifically
interacts with the activated, GTP-bound conformation of
rab1. Interestingly, Iporin also showed an interaction with
the rab1 homolog from yeast Ypt1p, indicating that for-
mation of this protein/protein complex is conserved dur-
ing evolution.
Northern blot analysis of Iporin mRNA revealed an ubiq-
uitous expression pattern (Figure 4). Highest amounts of
Iporin mRNA were observed in brain and testis,
suggesting that Iporin might have a distinctive role in
these tissues. Neurogenesis as well as spermatogenesis are
Tissue-specific expression of Iporin mRNA Figure 4
Tissue-specific expression of Iporin mRNA. A 12-lane 
multiple-tissue Northern blot was hybridized with a specific 
32P-labeled cDNA probe for Iporin. Each lane contains 
approximately 2 µg of poly A+ from various tissues. The blot 
was exposed to an X-ray film for 17 h at -80°C with an 
amplifying screen. To confirm equal loading, the membrane 
was re-hybridized with a radiolabeled probe specific for β -
actin mRNA.BMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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Cellular distribution of Iporin Figure 5
Cellular distribution of Iporin. (Aa) To test specificity of the polyclonal anti Iporin antibody Aip519, HeLa cells were tran-
siently transfected with HA-tagged Iporin. After lysis, cell extracts were blotted and incubated with the Aip519 and the mono-
clonal 16B12 anti HA antibody, respectively. The Western blot displays a signal of about 220 kDa for both antibodies. (Ab) 
Cytosol/membrane fractionation with extracts from transiently transfected HeLa cells. Recombinant HA-Iporin was detected 
with anti HA (16B12) antibody. Fractionation of full-length HA-Iporin and HA-Iporin ∆ N847 revealed that most of the recom-
binant proteins were present in the membrane fraction (P100) with small amounts in the cytosolic (S100) fraction. In contrast, 
the transiently expressed HA-Iporin ∆ C853 was present in a high concentration in the cytosolic (S100) fraction. (Ac) Compar-
ison between untransfected and HA-rab1bQ67L transfected HeLa cells. Blots were analyzed using the Aip519 (Iporin), anti-
GM130 (GM130), anti-p115 (p115), anti-calnexin and 1E7 (anti-rab1b) antibodies. (B) Immunofluorescence staining of recom-
binant HA-Iporin expressed in HeLa cells shows a cytosolic distribution with a perinuclear enrichment in spotted structures. 
Bar 10 µm.BMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
Page 10 of 15
(page number not for citation purposes)
Interaction of Iporin with GM130 Figure 6
Interaction of Iporin with GM130. (A) Yeast co-transformations revealed an interaction between Iporin and GM130. 
Using different GM130 deletion mutants, we were able to map the binding site to the coiled-coil region 6 (Figure 6A). The bait 
construct Iporin∆ N847∆ C1239 was cloned into the pAS2-1 vector and the prey constructs into pGADT7. Clones were culti-
vated on selection plates as described previously (see Table 1). = no growth on selection plates or no β -galactosidase activity; 
++ = strong growth or β -galactosidase activity appears after a few hours; +++ = very fast growth or high β -galactosidase activ-
ity (B) GST-pulldown of endogenous GM130 with GST-Iporin∆ N847∆ C1239 or GST-Iporin ∆ N1430. After incubation with 
HeLa cell extracts, GST-Iporin∆ N847∆ C1239 showed an interaction with GM130, whereas GST-Iporin ∆ N1430 did not bind 
to GM130. The lower panel shows the Coomassie blue stained blot membrane with equal amounts of GST fusion protein.BMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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processes that result in the production of highly polarized
cells and we speculate that Iporin might act as a regulator
in these cellular systems [41].
Applying a set of deletion mutants and chimeras of rab1,
we demonstrated that the Iporin binding domain is local-
ized within the N-terminal half of rab1 and that the rab1
N-terminal hypervariable region is essential for the inter-
action (Figure 1). In contrast to PRA1, another known
rab1 effector protein, our results show that the
prenylation site of the rab1 GTPase is not necessary for the
binding to Iporin [42]. A well characterized interaction
between a rab GTPase and an effector molecule is the
rab3a/rabphillin-3a interacting complex [43]. The specific
interaction of rab3a with rabphillin-3a is mediated
through a rab3a "pocket" contributed by three rab com-
plementary-determining regions (RabCDR), which are
localized at the N- and C-terminus. The RabCDRs are pro-
posed to form regions of variable sequences among the
rab family within a structural conserved framework and
act as a structural element for protein/protein interactions
[43]. This model was supported by the work of Seabra and
co-workers. They defined a model of conserved regions
within the rab family (RabF) and regions only conserved
among the rab isoforms (RabSF) [31]. Projected on a three
dimensional model of rab3a, the previously described
RabCDR regions are represented by the RabSF1, 3 and 4
regions. They form one interaction surface and the RabSF2
region forms another surface, almost on the opposite side
[31]. The data presented here about the interaction of the
rab1b Q67R deletion mutants and the permanently active
rab1b/rab6a chimeras with Iporin and Iporin ∆ 847,
respectively, revealed that the N-terminal half of rab1b,
including RabSF1 and RabSF2, is essential for the interac-
tion with Iporin (Figure 1B). The C-terminal elements,
comprising RabSF3 and RabSF4, do not play a role in the
formation of the complex and may be necessary for struc-
tural reasons only. Surprisingly, this is in contrast to the
results received from the rab3a/rabphillin-3a complex.
Our data suggest that Iporin is able to interact with parts
of both interaction surfaces. Thus, these results support
the theory of a multi-protein interaction interface, where
molecules can interact with different parts of both
surfaces.
To date, four proteins (p115, GM130, golgin-84 and
MICAL) have been identified which interact specifically
with the activated conformation of rab1 [14-
17,25,27,28]. GM130 is a cis-Golgi-localized coiled-coil
protein, targeted to membranes via the peripheral mem-
brane protein GRASP65 [44]. Additionally, GM130 inter-
acts with activated rab1, rab2, rab33b, the vesicle
tethering-protein p115 and as we recently observed with
Iporin [15,45]. p115 has been identified to play a pivotal
role in docking of COPI vesicles to the Golgi membranes
by recruiting GM130 and Giantin in a long tethering com-
plex [21,22]. Giantin is a transmembrane protein, located
on COPI vesicles and shares similarities with the recently
identified golgin-84 and CASP [16,46,47]. It is worth to
note, that rab1 was also shown to recruit p115 during
budding to the ER-compartment to program COPII vesi-
cles for fusion [14]. Another aspect, which has been dis-
cussed to be required for tethering events at the ER-Golgi
stage are large multisubunit complexes like TRAPPI
(transport protein particle). TRAPPI has been identified in
yeast to function as tethering factor with GEF activity (gua-
nosine exchange factor) for Ypt1p [48,49]. The impor-
tance of this complex for mammalian transport steps
between ER and Golgi remains to be clarified, but the
increasing number of rab1 interacting molecules raises the
theory of a huge protein complex with rab1 in a central
position. Another possibility might be that activated rab1
only mediate interactions between other proteins, e.g.
Iporin and GM130, in a time or place dependent manner.
Iporin displays some features that are quite different from
the known rab1 interacting molecules. First GM130 as
well as golgin-84 contain coiled-coil regions that are
essential structural elements for the interaction with rab1
[15-17,28,50]. However, the rab1b binding domain of
p115 has not been characterized so far [14,51]. Iporin
contains no coiled-coil regions, but interacts via a RUN
domain with rab1 (see below). Second the known rab1
effector proteins are membrane-associated proteins,
which are involved in tethering processes between donor
and acceptor membranes at ER-Golgi compartments
[14,17,22,46]. Iporin displays a distribution (Figure 5Ab–
c, 5B), which is also different from known proteins
belonging to the tethering complex at Golgi membranes.
Similar to MICAL, the localization of Iporin is not
restricted to the ER-Golgi compartment leading to the
conclusion that, in contrast to GM130 or GRASP65,
Iporin is not a member of the Golgi matrix protein family
[15,24,27]. The cytosol/membrane fractionation of HeLa
cell extracts revealed a mainly membranous association
(P100) of transiently transfected and endogenous Iporin,
which is an evidence for a high and stable membranous
association through its function (Figure 5Ab–c). At this
step, Iporin might recruit further proteins to form a com-
plex needed for a regulative purpose.
Interestingly, the deletion mutants Iporin ∆ N847 and
Iporin ∆ C853 show a different distribution in the S100
fraction. Iporin ∆ C853 exhibits a cytosolic accumulation,
which is a hint for a much weaker accessibility to mem-
branes (Figure 5Ab). This accumulation seems to be due
to the missing carboxyterminal part of the protein and not
the result of overexpression effects (Figure 5Ab). To test
the influence of overexpressed permanently active rab1b,
we transiently transfected HeLa cells with HA-taggedBMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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rab1bQ67L and compared transfected to non-transfected
cells. The obtained data showed no significant effect on
Iporin membrane association (Figure 5Ac). One could
argue that the membrane association is not necessarily
coupled to the interaction with rab1. Like GM130, which
is linked via the GRASP65 protein to membranes, another
protein, not yet identified, might be responsible for the
attachment of Iporin to membranes. In addition, the over-
expression of HA-rab1bQ67L had also no effect on the
GM130 distribution, which interaction with rab1 is well
characterized. Another reason could be, that for the inter-
action with rab1 only a limited amount of Iporin is suffi-
cient and that the HA-rab1b Q67L compete with the GTP-
bound endogenous rab1b.
As mentioned before, Iporin contains a RUN and a SH3
domain as well as proline- and glutamic acid-rich regions.
These motifs have been described to function as targets for
protein/protein interactions [35,52,53]. The RUN domain
was previously shown to be part of the rap2 binding
region and is supposed to mediate the interaction
between the small GTPase rap2 and the effector protein
RPIP8 [35]. In contrast, the RUN domain of Rabip4, an
effector protein of the small GTPase rab4, has no influ-
ence on the interaction, but was supposed to be responsi-
ble for an association with a filamentous network [36].
We were able to map the rab1 interacting domain to a
RUN domain-containing region and we suggest a rab1-
specific interacting function for the RUN domain of
Iporin (Figure 3).
Using the phage display method we identified PPΨ X2M as
a new SH3 binding motif, which is different from the orig-
inally known PXXP motif [52]. The Iporin SH3 domain
together with the polyproline regions may act as regula-
tive targets for not yet identified interacting proteins. Such
a link was recently described for the small GTPase rab5.
RN-tre, a rab5-specific GTPase-activating protein (GAP)
interacts with Grb2. This association is mediated via the
SH3 domains of Grb2 and the proline-rich regions of RN-
tre [54].
Our recent discovery of an additional not yet identified
interaction partner of Iporin, the GM130, is a very inter-
esting piece of the "Golgi puzzle" (Figure 6). As has been
shown in this and previous manuscripts, both proteins,
the Iporin and GM130 interact with rab1 [15,17]. As men-
tioned above, GM130 is important for vesicle docking
processes at the cis-Golgi, where it interacts with p115.
GM130 itself is recruited to ER-derived vesicles and vesic-
ular-tubular clusters by the rab1 GTPase [50]. One could
speculate, that Iporin, while interacting with rab1b, spec-
ifies the recruitment of the incoming vesicle to the cis-
Golgi by displaying a high affinity to GM130 by finally
binding to this protein. The presented data showed that
the binding site of Iporin is different from other GM130
interacting proteins. p115 binds to the N-terminus, rab1b
to the coiled-coiled region 3 and GRASP65 to the C-termi-
nus of GM130 [15,18,44]. Iporin binds to the coiled-
coiled region 6 which means that they could bind in sev-
eral ways e.g. at the same time, one after another, two at
the same time, etc.
The multi-domain structure of Iporin and the cellular dis-
tribution suggest that this protein might act as an adapter
or scaffold protein, which links GTPases to certain intrac-
ellular signal transduction pathways. Noteworthy, Iporin
displays several features different from known rab1 effec-
tor proteins. Our data about the Iporin-rab1-GM130 asso-
ciation demonstrate once more, that the increasing
number of protein/protein interactions at different stages
of ER to Golgi transport implies a more complex regulated
network as originally thought.
Methods
Yeast two-hybrid assay
For the yeast two-hybrid screen we cloned human rab1b
Q67R cDNA into the pAS2-1 bait vector and transformed
Y190 as recommended by the Matchmaker II™ manual
(BD Biosciences Clontech, Heidelberg, Germany). The
bait yeast strain was then transformed with a human pla-
centa cDNA library (BD Biosciences Clontech, Heidel-
berg, Germany) as prey. In order to test the specificity of
the interaction between rab1b Q67R and putative binding
partners, Y190 yeast cells were co-transformed with vari-
ous bait and prey constructs and incubated on selection
plates at 30°C for 5–7 days as described by manufacturer's
instructions (BD Biosciences Clontech, Heidelberg, Ger-
many). A protein/protein interaction was confirmed by β -
galactosidase filter lift assays using X-gal as substrate. The
cDNAs of selected yeast clones were purified, transformed
into E. coli strain DH5α  and sequenced.
Cloning of the full-length Iporin sequence and generation 
of deletion mutants
To clone the full-length Iporin sequence, we amplified the
cDNA encoding the N-terminal region of Iporin (which is
represented by the Iporin ∆ C853 deletion mutant) using
the KIAA 0375 cDNA (generous gift from Takahiro
Nagase, Kazusa Institute, Japan) as template. We gener-
ated a primer with a 5' NdeI overhang containing the pre-
dicted start codon and a primer with a 3' EcoRI overhang
beyond a single endogenous HindIII restriction site, which
was also found in the original prey clone. The PCR prod-
uct, representing the N-terminal part, was digested with
NdeI/HindIII and was inserted into the eukaryotic expres-
sion vector pSV-HA [55]. In a second step, the initially iso-
lated prey cDNA encoding the C-terminal part of Iporin,
was digested with HindIII and was inserted into the pSV-
HA-N-terminal vector. To generate deletion mutants,BMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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fragments of Iporin cDNA were amplified with specific
primers containing 5' NdeI and 3' EcoRI sites and were
cloned into the pAS2-1 or pGADT7 vectors. Generation of
rab1b/rab6a chimeras was described previously [29]. All
resulting constructs were verified by sequencing. Details
are available from A. Barnekow.
Northern blot analysis
Multiple tissue Northern Blot (OriGene, Rockville, USA)
of poly (A+) RNA from various human tissues was hybrid-
ized with 32P-labeled Iporin ∆ N847 cDNA using the
RediPrime Nick Translation Kit (Amersham Biosciences,
Freiburg, Germany) according to the manufacturer's
instructions. The X-ray film was exposed for 17 h at -80°C
with an amplifying screen.
Antibodies
The polyclonal antibody Aip519 against Iporin was raised
in a rabbit immunized with GST-Iporin aa 848–991
(Eurogentech, Seraing, Belgium). The antibody was affin-
ity purified using the antigen coupled to NHS-Sepharose
(Amersham Biosciences, Freiburg, Germany). The mouse
monoclonal antibody 1E7 against rab1b has been
described earlier [55]. Mouse monoclonal antibodies
against Calnexin (anti-Calnexin), GM130 (anti-GM130),
p115 (anti-p115) and the HA-tag (16B12) were pur-
chased from BD Biosciences (Heidelberg, Germany) and
BAbCO (Berkely, USA), respectively. Secondary antibod-
ies coupled to peroxidase were purchased from Amer-
sham Biosciences (Freiburg, Germany).
Expression and purification of recombinant proteins
GST-Iporin ∆ N847∆ C992 fusion protein, used for immu-
nization and GST-Iporin ∆ N1430 (encoding the SH3
domain) used for the phage display method (see below)
were expressed in E. coli strain BL21 induced with 1 mM
IPTG for 3 h at 30°C. The pelleted bacteria were washed,
resuspended in PBS containing protease inhibitors (com-
plete™, EDTA-free, Roche Diagnostics, Mannheim, Ger-
many) and sonicated 10x for 10 sec. Triton X-100 was
added to 1% final concentration and the lysate was incu-
bated on ice for 30 min. After centrifugation at 16000 × g
the cleared supernatant was incubated with glutathione-
Sepharose beads for 30 min at 4°C. The beads were
washed twice with chilled PBS and the fusion protein was
eluted with 50 mM Tris-HCl, pH 8.0, containing 10 mM
reduced glutathione. Samples were dialyzed against PBS
overnight. The recombinant proteins used for GST-pull-
down experiments were treated as described above with-
out the elution and dialyzation step. Cleared supernatants
were stored at -80°C until use.
In vitro binding assay
GST-pulldown assays were performed using bacterially
expressed GST fusion proteins containing the deletion
mutants Iporin ∆ N847∆ C1239,  ∆ N847∆ C992 and
∆ N1430. Equal amounts of the GST fusion proteins or
GST were immobilized on 10 µl packed glutathione-
Sepharose beads and incubated overnight at 4°C. After
the beads were washed three times with LB buffer (10 mM
Tris pH7.4, 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2,
0.2% Triton X-100, complete™ EDTA-free, Roche Diag-
nostics, Mannheim, Germany), they were incubated with
cytosolic extract from BHK cells, transiently transfected
with pSV-HA-rab1b Q67R using the Ca-phosphate/DNA
precipitation method [56]. To prepare the cytosolic
extract, BHK or HeLa cells were washed three times with
chilled PBS and scraped in a volume of 300 µl LB buffer.
After homogenization by 15 passes through a 25 gauge
needle, lysates were centrifuged at 14000 × g, 4°C for 1 h.
The beads containing tubes were incubated for 3 h at 4°C
on a rocking platform, supplemented with 50 µl goat
serum and were adjusted with LB to a total volume of 300
µl. Beads were recovered by centrifugation, washed three
times with 500 µl LB. Proteins were eluted by boiling the
beads in SDS sample buffer analyzed by SDS/PAGE and
Western blotting. The GM130-pulldown was performed
as above with untransfected HeLa cell extracts and with-
out the supplementation of goat serum.
Cell lines
BHK and HeLa cells were grown in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 10% fetal
calf serum and 1% glutamine at 37°C in a humidified 5%
CO2 incubator.
Cytosol/membrane fractionation
HeLa cells were grown on 10 cm tissue culture plates and
transiently transfected with different pSV-HA-Iporin con-
structs or pSV-HA-rab1bQ67L using the Ca-phosphate/
DNA precipitation method. After 20 hrs, cells were
washed three times with chilled PBS, freezed at -80°C,
thawed and scraped into 300 µl CMF buffer (250 mM
sucrose, 10 mM Hepes/KOH pH 7.4, 1 mM EDTA, com-
plete™ EDTA-free, Roche Diagnostics, Mannheim, Ger-
many). Cells were homogenized by 15 passes through a
25 gauge needle and centrifuged at 1000 × g, 4°C for 2
min. The resulting PNS (postnuclear supernatant) was
underlayered with 10 µl of 50% sucrose and centrifuged at
14000 × g and 4°C for 15 min. The supernatant was cen-
trifuged for a second time at 100000 × g and 4°C for 1 h,
which provided the S100 supernatant and the P100 pellet
fraction. The P100 pellet was washed with 200 µl of CMF
and centrifuged once more. Samples were analyzed by
SDS/PAGE and Western blotting.
Immunofluorescence analysis
HeLa cells were grown at 40–60% confluency on cover-
slips and transiently transfected using the Polyfect trans-
fection reagent (Qiagen, Hilden, Germany) according toBMC Cell Biology 2005, 6:15 http://www.biomedcentral.com/1471-2121/6/15
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manufacturer's instructions. After 24 hrs, the cells were
washed with chilled PBS and fixed for 5 min. in 100%
methanol at -20°C. The fixed cells were washed in PBS
and blocked for 20 min. in PBS supplemented with 10%
(v/v) goat serum. Monoclonal anti-HA tag antibodies
(16B12) were diluted in PBS containing 2% (v/v) goat
serum and incubated with the cells for 30 min. at RT. After
washing with PBS, Alexa Fluor 488-conjugated goat anti-
mouse IgGs were applied for 30 min. The cells were
washed again with PBS, rinsed in water and mounted in
Mowiol 4–88 (Calbiochem, Bad Soden, Germany).
Phage display
The fUSE5/15-mer M13 phage displayed random peptide
library was screened with purified GST-Iporin ∆ N1430
fusion protein containing the SH3 domain of Iporin. The
used library consists of 2 × 108 primary clones and con-
tains a foreign 15-mer oligopeptide on all 5 copies of pIII.
The method was performed as described previously [57].
Briefly, 2 µg of purified GST-Iporin ∆ N1430 fusion pro-
tein was immobilized on the surface of a 96 well plate and
incubated with ~1013 plaque forming units of the phage
displayed random peptide library. The bound phages
were washed, eluted, amplified and incubated again with
newly immobilized GST-Iporin ∆ N1430 fusion protein
for a second and third round to purify the bound phages.
The isolated phages were tested with GST as negative and
GST-Iporin ∆ N1430 fusion protein as positive controls by
the Detection Module Recombinant Phage Antibody Sys-
tem (Amersham Biosciences, Freiburg, Germany)
according to the manufacturer's instructions. The DNA
from positive clones was isolated and sequenced.
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